MDS (MYELODYSPLASTIC SYNDROME)
Clinical trials for MDS (MYELODYSPLASTIC SYNDROME) explained in plain language.
Never miss a new study
Get alerted when new MDS (MYELODYSPLASTIC SYNDROME) trials appear
Sign up with your email to follow new studies for MDS (MYELODYSPLASTIC SYNDROME), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a broccoli compound revive old cord blood transplants? new study aims to find out.
Disease control Recruiting nowThis study tests whether a dietary supplement called sulforaphane (found in broccoli) can safely help blood cell recovery in adults receiving a cord blood transplant for blood cancers like leukemia or myelodysplastic syndrome. The cord blood used has been frozen for 10 years or m…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 17, 2026 03:16 UTC
-
New hope for elderly blood cancer patients: tailored transplant approach shows promise
Disease control Recruiting nowThis study tests a new combination of drugs (cladribine, lisaftolax, and busulfan) given before a stem cell transplant in 30 older adults (50+) with relapsed or hard-to-treat acute myeloid leukemia or myelodysplastic syndromes. The goal is to make the transplant safer and more ef…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
Double stem cell transplant shows promise for tough blood cancers
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS). It uses stem cells from a half-matched family donor plus umbilical cord blood, given a few days apart, to help the body accept the new…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: NA • Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
Weekly shot may speed platelet recovery after transplant in blood disorders
Disease control Recruiting nowThis study tests whether a once-weekly injection (romiplostim) can help platelets recover faster and more safely after a donor stem cell transplant in people with myelodysplastic syndrome (MDS) or severe aplastic anemia. About 66 adults will be randomly assigned to receive either…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
Could bone marrow from deceased donors treat blood cancers?
Disease control Recruiting nowThis early-phase study tests whether bone marrow from deceased donors can be safely used for people with blood cancers like leukemia and lymphoma. About 12 patients will receive a transplant after chemotherapy, and doctors will monitor for side effects and blood cell recovery for…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding a special type of immune cell (memory T cells) after a donor stem cell transplant can help prevent serious viral and fungal infections. It involves up to 100 children and young adults with blood cancers or immune disorders. The approach aims to spe…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1, PHASE2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough blood cancers: experimental drug CG009301 enters human testing
Disease control Recruiting nowThis early-phase study tests a new drug called CG009301 in adults with blood cancers (like leukemia or MDS) that returned or didn't respond to standard treatments. The main goals are to find a safe dose and check for side effects. About 45 participants will receive the drug until…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1 • Sponsor: Cullgen (Shanghai),Inc • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for tough blood cancers: ARD103 trial opens
Disease control Recruiting nowThis study tests a new drug called ARD103 in about 49 adults whose acute myeloid leukemia or myelodysplastic syndrome has returned or not improved with standard treatments. The goal is to find a safe dose and see if the drug can shrink or control the cancer. Participants will rec…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1, PHASE2 • Sponsor: ARCE Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Safer stem cell transplants? new study aims to reduce Life-Threatening side effects
Disease control Recruiting nowThis study tests a new way to do stem cell transplants for people with severe aplastic anemia and other bone marrow failure diseases. The goal is to lower the risk of serious complications, like graft-versus-host disease, by giving fewer donor white blood cells. Participants rece…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
New drug cocktails aim to tame transplant complications in blood cancer patients
Disease control Recruiting nowThis study tests new drug combinations to prevent graft-versus-host disease (GVHD) in people with blood cancers who receive stem cells from an unrelated donor. About 358 participants will get either the standard GVHD prevention drugs or a new mix, and researchers will compare whi…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New drug combo aims to free MDS patients from frequent blood transfusions
Disease control Recruiting nowThis study tests whether combining two drugs, luspatercept and darbepoetin alfa, can help people with a certain type of lower-risk myelodysplastic syndrome (MDS) go without blood transfusions for at least 12 weeks. The trial enrolls 60 adults who currently need regular red blood …
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
New drug aims to speed platelet recovery in blood cancer transplants
Disease control Recruiting nowThis study tests a drug called romiplostim N01 to see if it can help platelets recover faster after a stem cell transplant in people with blood cancers like leukemia. About 130 participants will either get the drug or standard care. The goal is to reduce bleeding risk and improve…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Phase: PHASE1 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Smartwatches could help doctors personalize blood transfusions for cancer patients
Knowledge-focused Recruiting nowThis study is for 80 adults with blood cancers like MDS or AML who are starting treatment. Researchers will give them a smartwatch to track activity and ask them to fill out surveys about how they feel. The goal is to see how low blood counts affect quality of life and find bette…
Matched conditions: MDS (MYELODYSPLASTIC SYNDROME)
Sponsor: University of Oxford • Aim: Knowledge-focused
Last updated May 14, 2026 12:07 UTC